Distortion in transmission of pathogenic SDHB- and SDHD-mutated alleles from parent to offspring

Author:

Davidoff Dahlia F123,Lim Eugénie S45ORCID,Benn Diana E12,Subramaniam Yuvanaa5,Dorman Eleanor5,Burgess John R67,Akker Scott A45ORCID,Clifton-Bligh Roderick J123ORCID

Affiliation:

1. Cancer Genetics, Kolling Institute, Royal North Shore Hospital, St Leonards, New South Wales, Australia

2. University of Sydney, Camperdown, New South Wales, Australia

3. Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia

4. Department of Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK

5. Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

6. Department of Diabetes and Endocrinology, Royal Hobart Hospital, Hobart, Tasmania, Australia

7. School of Medicine, University of Tasmania, Hobart, Tasmania, Australia

Abstract

Phaeochromocytoma and paraganglioma are highly heritable tumours; half of those associated with a germline mutation are caused by mutations in genes for Krebs’s cycle enzymes, including succinate dehydrogenase (SDH). Inheritance of SDH alleles is assumed to be Mendelian (probability of 50% from each parent). The departure from transmission of parental alleles in a ratio of 1:1 is termed transmission ratio distortion (TRD). We sought to assess whether TRD occurs in the transmission of SDHB pathogenic variants (PVs). This study was conducted with 41 families of a discovery cohort from Royal North Shore Hospital, Australia, and 41 families from a validation cohort from St. Bartholomew’s Hospital, United Kingdom (UK). Inclusion criteria were a clinically diagnosed SDHB PV and a pedigree available for at least two generations. TRD was assessed in 575 participants with the exact binomial test. The transmission ratio for SDHB PV was 0.59 (P = 0.005) in the discovery cohort, 0.67 (P < 0.001) in the validation cohort, and 0.63 (P < 0.001) in the combined cohort. No parent-of-origin effect was observed. TRD remained significant after adjusting for potential confounders: 0.67 (P < 0.001) excluding families with incomplete family size data; 0.58 (P < 0.001) when probands were excluded. TRD was also evident for SDHD PVs in a cohort of 81 patients from 13 families from the UK. The reason for TRD of SDHB and SDHD PVs is unknown, but we hypothesize a survival advantage selected during early embryogenesis. The existence of TRD for SDHB and SDHD has implications for reproductive counselling, and further research into the heterozygote state.

Publisher

Bioscientifica

Subject

Cancer Research,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Reference22 articles.

1. Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options;Antonio,2020

2. Bayesian approach to determining penetrance of pathogenic SDH variants;Benn,2018

3. Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal);Bettencourt,2008

4. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity;Dahia,2014

5. HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models;Dard,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3